|High-potency cannabis and the risk of psychosis|
M Di Forti, C Morgan, P Dazzan, C Pariante, V Mondelli, TR Marques, ...
The British Journal of Psychiatry 195 (6), 488-491, 2009
|Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study|
M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta, M Bonomo, F Bianconi, ...
The Lancet Psychiatry 2 (3), 233-238, 2015
|Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users|
M Di Forti, H Sallis, F Allegri, A Trotta, L Ferraro, SA Stilo, A Marconi, ...
Schizophrenia bulletin 40 (6), 1509-1517, 2014
|Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology|
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
|Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment|
V Mondelli, P Dazzan, N Hepgul, M Di Forti, M Aas, A D'Albenzio, ...
Schizophrenia research 116 (2-3), 234-242, 2010
|Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users|
M Di Forti, C Iyegbe, H Sallis, A Kolliakou, MA Falcone, A Paparelli, ...
Biological psychiatry 72 (10), 811-816, 2012
|Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium|
TGM Van Erp, E Walton, DP Hibar, L Schmaal, W Jiang, DC Glahn, ...
Biological psychiatry 84 (9), 644-654, 2018
|Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis|
V Mondelli, S Ciufolini, M Belvederi Murri, S Bonaccorso, M Di Forti, ...
Schizophrenia bulletin 41 (5), 1162-1170, 2015
|The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment|
AH Ashok, TR Marques, S Jauhar, MM Nour, GM Goodwin, AH Young, ...
Molecular psychiatry 22 (5), 666-679, 2017
|Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis|
V Mondelli, CM Pariante, S Navari, M Aas, A D'Albenzio, M Di Forti, ...
Schizophrenia research 119 (1-3), 75-78, 2010
|An examination of polygenic score risk prediction in individuals with first-episode psychosis|
E Vassos, M Di Forti, J Coleman, C Iyegbe, D Prata, J Euesden, P O’Reilly, ...
Biological psychiatry 81 (6), 470-477, 2017
|Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses|
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ...
Psychological Medicine 46 (15), 3231-3240, 2016
|White matter integrity as a predictor of response to treatment in first episode psychosis|
T Reis Marques, H Taylor, C Chaddock, F Dell’Acqua, R Handley, ...
Brain 137 (1), 172-182, 2014
|Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis|
M Aas, P Dazzan, V Mondelli, T Toulopoulou, A Reichenberg, M Di Forti, ...
Psychological medicine 41 (3), 463, 2011
|Acute effects of single‐dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain|
R Handley, FO Zelaya, AATS Reinders, TR Marques, MA Mehta, ...
Human brain mapping 34 (2), 272-282, 2013
|Cortical folding defects as markers of poor treatment response in first-episode psychosis|
L Palaniyappan, TR Marques, H Taylor, R Handley, V Mondelli, ...
JAMA psychiatry 70 (10), 1031-1040, 2013
|Childhood trauma is associated with increased Body Mass Index and increased C-reactive protein levels in first-episode psychosis patients|
N Hepgul, CM Pariante, S Dipasquale, M DiForti, H Taylor, TR Marques, ...
Psychological medicine 42 (9), 1893, 2012
|Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease|
F Niccolini, S Haider, T Reis Marques, N Muhlert, AC Tziortzi, GE Searle, ...
Brain 138 (10), 3016-3029, 2015
|Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease|
F Niccolini, T Foltynie, T Reis Marques, N Muhlert, AC Tziortzi, GE Searle, ...
Brain 138 (10), 3003-3015, 2015
|Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures|
EF Osimo, K Beck, TR Marques, OD Howes
Molecular psychiatry 24 (4), 549-561, 2019